|
|
West J Med. 1996 October; 165(4): 231–233. | PMCID: PMC1303758 |
Lysinuric protein intolerance presenting as coma in a middle-aged man. M Gare, M Shalit, and A Gutman Department of Internal Medicine, Michael Reese Hospital, Chicago, Illinois 60616, USA. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (562K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Perheentupa J, Visakorpi JK. Protein intolerance with deficient transport of basic aminoacids. Another inborn error of metabolism. Lancet. 1965 Oct 23;2(7417):813–816. [PubMed]
- Malmquist J, Jagenburg R, Lindstedt G. Familial protein intolerance. Possible nature of enzyme defect. N Engl J Med. 1971 May 6;284(18):997–1002. [PubMed]
- Rajantie J, Simell O, Perheentupa J. Basolateral-membrane transport defect for lysine in lysinuric protein intolerance. Lancet. 1980 Jun 7;1(8180):1219–1221. [PubMed]
- Rajantie J, Simell O, Perheentupa J. Lysinuric protein intolerance. Basolateral transport defect in renal tubuli. J Clin Invest. 1981 Apr;67(4):1078–1082. [PubMed]
- Rajantie J, Simell O, Perheentupa J. "Basolateral" and mitochondrial membrane transport defect in the hepatocytes in lysinuric protein intolerance. Acta Paediatr Scand. 1983 Jan;72(1):65–70. [PubMed]
- Oyanagi K, Sogawa H, Minami R, Nakao T, Chiba T. The mechanism of hyperammonemia in congenital lysinuria. J Pediatr. 1979 Feb;94(2):255–257. [PubMed]
- Carpenter TO, Levy HL, Holtrop ME, Shih VE, Anast CS. Lysinuric protein intolerance presenting as childhood osteoporosis. Clinical and skeletal response to citrulline therapy. N Engl J Med. 1985 Jan 31;312(5):290–294. [PubMed]
- Kerem E, Elpelg ON, Shalev RS, Rosenman E, Bar Ziv Y, Branski D. Lysinuric protein intolerance with chronic interstitial lung disease and pulmonary cholesterol granulomas at onset. J Pediatr. 1993 Aug;123(2):275–278. [PubMed]
- Rajantie J, Simell O, Perheentupa J. Oral administration of epsilon N-acetyllysine and homocitrulline in lysinuric protein intolerance. J Pediatr. 1983 Mar;102(3):388–390. [PubMed]
- Treem WR. Inherited and acquired syndromes of hyperammonemia and encephalopathy in children. Semin Liver Dis. 1994 Aug;14(3):236–258. [PubMed]
- Chan H, Billmeier GJ, Jr, Molinary SV, Tucker HN, Shin BC, Schaffer A, Cavallo K. Prolonged coma and isoelectric electroencephalogram in a child with lysinuric protein intolerance. J Pediatr. 1977 Jul;91(1):79–81. [PubMed]
- Rajantie J, Simell O, Rapola J, Perheentupa J. Lysinuric protein intolerance: a two-year trial of dietary supplementation therapy with citrulline and lysine. J Pediatr. 1980 Dec;97(6):927–932. [PubMed]
- Shaw PJ, Dale G, Bates D. Familial lysinuric protein intolerance presenting as coma in two adult siblings. J Neurol Neurosurg Psychiatry. 1989 May;52(5):648–651. [PubMed]
- Fakler CR, Kaftan HA, Nelin LD. Two cases suggesting a role for the L-arginine nitric oxide pathway in neonatal blood pressure regulation. Acta Paediatr. 1995 Apr;84(4):460–462. [PubMed]
- Wakabayashi Y, Yamada E, Yoshida T, Takahashi H. Deficiency of endogenous arginine synthesis provokes hypertension by exhausting substrate arginine for nitric oxide synthesis. Biochem Biophys Res Commun. 1994 Dec 15;205(2):1391–1398. [PubMed]
|
